PPA
CTIC

Parametric Portfolio Associates’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Parametric Portfolio Associates’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$1.1M Buy
+236,065
New +$704K ﹤0.01% 2735
2019
Q1 		– Sell
-44,554
Closed -$33K – 4041
2018
Q4 		$33K Buy
44,554
+729
+2% +$1.2K ﹤0.01% 3872
2018
Q3 		$95K Buy
+43,825
New +$109K ﹤0.01% 3854
2015
Q3 		– Sell
-2,031
Closed -$40K – 3540
2015
Q2 		$40K Buy
2,031
+137
+7% +$2.64K ﹤0.01% 3933
2015
Q1 		$34K Buy
1,894
+611
+48% +$13.8K ﹤0.01% 3920
2014
Q4 		$30K Sell
1,283
-1,267
-50% -$29.3K ﹤0.01% 3965
2014
Q3 		$62K Buy
+2,550
New +$66.3K ﹤0.01% 3763
2014
Q2 		– Sell
-2,233
Closed -$76K – 3926
2014
Q1 		$76K Buy
2,233
+17
+0.8% +$581 ﹤0.01% 3760
2013
Q4 		$42K Buy
+2,216
New +$40.3K ﹤0.01% 3792

Other funds holding CTIC

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return